F43.10 is an ICD-10-CM diagnosis code for post-traumatic stress disorder (PTSD), unspecified. It falls under the broader category of stress-related disorders and is the code used when a clinician diagnoses PTSD but doesn’t specify whether the condition is acute or chronic. You might encounter this code on medical bills, insurance paperwork, or electronic health records.
How F43.10 Relates to Other PTSD Codes
The ICD-10 coding system breaks PTSD into three levels of specificity. F43.10 is the general, “unspecified” version. The two more specific codes are F43.11 (acute PTSD, where symptoms have lasted less than three months) and F43.12 (chronic PTSD, where symptoms persist beyond three months). If your paperwork shows F43.10, it simply means the duration wasn’t documented at the time of coding, not that your diagnosis is less valid or less serious.
What PTSD Actually Involves
PTSD is an anxiety disorder that develops after exposure to a traumatic event, typically one involving intense fear, horror, or a threat to life. Around 70% of people worldwide experience a potentially traumatic event at some point, but only about 5.6% go on to develop PTSD. The global lifetime prevalence sits at roughly 3.9%, though rates climb above 15% among people exposed to violent conflict or war.
Symptoms must last longer than one month and cause real disruption to daily life. They fall into four clusters:
- Re-experiencing the trauma: unwanted memories that intrude without warning, nightmares, flashbacks that feel like the event is happening again, or intense emotional and physical reactions to reminders of the trauma.
- Avoidance: steering clear of thoughts, feelings, places, or people connected to the traumatic event.
- Negative changes in thinking and mood: persistent guilt or blame, feeling detached from others, losing interest in activities, difficulty experiencing positive emotions, or an inability to remember key parts of what happened.
- Heightened arousal and reactivity: being easily startled, feeling constantly on edge, trouble sleeping, difficulty concentrating, irritability, or engaging in reckless behavior.
Some people also describe feeling like they’re watching themselves from outside their body, or like the world around them isn’t real. PTSD frequently overlaps with other conditions. About 80% of people with PTSD have at least one additional mental health diagnosis, most commonly depression, substance use disorders, or other anxiety disorders.
Who Is Most at Risk
Not everyone who lives through a traumatic event develops PTSD. Several factors increase vulnerability. Women are diagnosed at nearly twice the rate of men, largely due to a particular vulnerability to assaultive violence. A history of prior trauma, especially trauma experienced in childhood, is one of the strongest predictors. Previous assault is an especially potent risk factor for developing PTSD after a later traumatic event.
Family instability, lower income, lower education levels, and being divorced or widowed all raise the odds. Pre-existing mental health conditions like depression, anxiety, or substance use disorders do too. On the biological side, researchers have found that people who go on to develop PTSD tend to show elevated heart rates immediately after a traumatic event, suggesting their stress response system processes the experience differently from the start. Strong social support, on the other hand, consistently lowers symptom severity.
How PTSD Is Treated
The most effective treatments for PTSD are trauma-focused psychotherapies. Cognitive Processing Therapy (CPT) and Prolonged Exposure (PE) therapy carry the strongest recommendations across clinical guidelines. Both involve working through the traumatic experience in a structured way, and both produce measurable improvements. In a large comparison study of veterans treated between 2007 and 2017, completing eight or more sessions of PE was associated with nearly 10 points of additional improvement on a standard PTSD symptom scale compared to other forms of therapy. CPT showed about 6 points of additional improvement.
Most treatment courses run 12 to 16 weekly sessions. On average, about 50% of patients recover within 15 to 20 sessions based on self-reported symptoms. Some people prefer to continue for 20 to 30 sessions over six months to solidify their progress. Those with co-occurring conditions may need 12 to 18 months of therapy for full benefit.
Two medications are FDA-approved specifically for PTSD: sertraline (Zoloft) and paroxetine (Paxil), both of which work by increasing serotonin activity in the brain. Venlafaxine (Effexor), which boosts both serotonin and norepinephrine, also has strong supporting evidence. Medication is often used alongside therapy, particularly when symptoms are severe or when depression is also present.
What Recovery Looks Like
PTSD is not necessarily a lifelong condition. Up to 40% of people recover within the first year, even without formal treatment. With evidence-based therapy, the odds improve substantially. Recovery doesn’t always mean the memory of the trauma disappears. It means the memory loses its power to hijack your daily life: the flashbacks ease, sleep improves, and the constant state of alertness gradually fades. A small minority of people with chronic, complex cases may need longer-term maintenance therapy, but most people who engage in treatment see meaningful improvement within months.